Background. The aim of this study was to assess plasma levels of endothelium- and heart-associated microRNAs (miRNAs) miR-126 and miR-499, respectively, using quantitative reverse transcriptase polymerase chain reaction. Methods: A two-step analysis was conducted on 75 patients undergoing off-pomp coronary artery bypass graft (CABG) surgery. Five biomarkers of inflammation and cardiac injury were assessed in addition to the abovementioned miRNAs. Results. Plasma concentrations of miRNAs were found to be significantly correlated with plasma levels of cardiac troponin I (cTnI) (miR-499, r 0.49, p~0.002; miR-126, r = 0.30, p~0.001), indicating cardiac damage. Data analysis revealed that miR-499 had higher sensitivity and specificity for cardiac injury than miR-126, which reflects more endothelial activation. Interestingly, a strong correlation was observed between both miRNAs and uric acid (UA) levels with ventricular contractility measured as ejection fraction (EF) (miR-499/EF%, r = 0.58, p~0.004; UA/EF%, r = -0.6, p~0.006; UA/miR-499, r = -0.34; UA/miR-126, r = 0.5, p~0.01). Conclusions. In patients undergoing CABG, circulating miR-126/499 is associated with presentation of traditional risk factors and reflects post-operative response to injury. Plasma pool of miRNAs likely reflects extracellular miRNAs which are proportional to intracellular miRNA levels. Therefore, circulating levels of these miRNAs have prognostic implications in detection of higher risk of future cardiovascular events.
CABG, Cardiac damage, miR-126, miR-499, Off-pomp, Uric acid
Financial support: No financial support has been received for this
Related Content In Heart failure
Quantification of Seasonal Variation in Daily Physical Activity in Individuals with Heart Failure and Implantable Cardioverter Defibrillator/Cardiac Resynchronisation Therapy Devices
Heart International. 2019;13(2):31–7
In individuals with heart failure (HF) who also have implanted cardioverter defibrillators and/or cardiac resynchronisation therapy (ICD/CRT) devices, low daily physical activity (PA) levels lead to increased risk of mortality, poor aerobic capacity and lower health-related quality of life.1 Improving daily PA in these individuals may, therefore, be an important clinical endpoint; however, designing interventional […]
Normalised Heart Rate Variability After Sacubitril/Valsartan
European Journal of Arrhythmia & Electrophysiology. 2019;5(1):60-1 DOI: https://doi.org/10.17925/EJAE.2019.5.1.60
We report the case of a 44-year-old woman with a history of chronic heart failure with reduced ejection fraction (HFrEF) due to ischemic cardiomyopathy (New York Heart Association [NYHA] class II). In 2010, she had a myocardial infarction with thrombotic occlusion of the left anterior descending coronary artery, alleged in the context of an essential thrombocythaemia. […]
Electronic and Mobile Health in Chronic Heart Failure
European Journal of Arrhythmia & Electrophysiology. 2018;4(2):45–6 DOI: https://doi.org/10.17925/EJAE.2018.4.2.45
In recent years, there has been increasing realisation that electronic health (e-health) – an umbrella term for multiple approaches to using information and communication technologies in health care – can encourage optimised and personalised delivery of care.1 Effective e-health initiatives may have benefits for both patient outcomes – through better education, information and self-management – […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!